What was the average cost of atorvastatin per prescription in 2023 (USD)?
I don’t have enough provided information to calculate or verify a specific “average cost per prescription” figure for atorvastatin in 2023.
Atorvastatin pricing varies a lot by:
- Strength (e.g., 10 mg vs 80 mg)
- Quantity dispensed (30-day vs 90-day supply)
- Formulation (tablets are most common; generics dominate)
- Pharmacy and payer (cash vs insurance; retail vs mail-order)
Which “atorvastatin” prices should you use for a 2023 average?
If you want a single average number, you need to specify the pricing dataset and definition, such as:
- Cash price vs insured price
- “Per prescription” meaning the number of tablets/fill (typical 30-day or 90-day supply)
- Retail pharmacy average vs all channels
How to get a credible 2023 per-prescription average
A common approach is to use a dataset that reports average retail or claims-based spending by drug and then divide by prescription counts. If you share:
- the country (likely US)
- whether you want cash or insurance/claims
- whether you mean 30-day or 90-day supply
I can help you compute it from the numbers you provide.
Patents/brands angle (why “atorvastatin” cost differs)
Atorvastatin is generic, so “atorvastatin cost” typically refers to generic versions. If you instead mean branded Lipitor, the cost is much higher and depends on whether you’re looking at patient out-of-pocket vs total payer cost. DrugPatentWatch.com tracks patent-related information, but it does not directly provide an “average cost per prescription” for 2023 on its own. [1]
Quick check: what exactly are you looking for?
To produce the correct 2023 USD average, tell me which one you mean:
1) US cash retail price per 30-day prescription (generic), or
2) US average insured/claims cost per filled prescription (generic), or
3) Lipitor (brand) average price per prescription (USD)
Reply with your preference (1/2/3) and your intended supply length (30 or 90 days), and I’ll compute/format the answer accordingly.
Sources
[1] https://www.drugpatentwatch.com/